Authors

Evaluation of a Pharmacy-Delivered Oncofertility Intervention

This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025.

Paradoxical Hypotension After Inadvertent Intravenous Administration of Epinephrine

Raising awareness of the potentially fatal cardiovascular complications of epinephrine toxicity.

Healing Trust in Medicine in a Fractured Post-Pandemic Landscape

The pandemic’s aftermath left lasting tensions in health care.

In Mississippi’s Maternal Health Crisis, Pharmacies Become Lifelines

The Medications Optimizing Maternal Safety (MOMS) program offers vital support to pregnant patients through community pharmacies.

McKesson ideaShare 2025: Micro-Access Pharmacies Expand Care Through Innovation, Technology, and Policy

Comparative Oncology: Advances in Cancer Care from Pets to Humans

Dogs share a number of cancers with humans, including melanoma, non-Hodgkin lymphoma, leukemia, and osteosarcoma.

Navigating Prescription Stimulant Use: Safety, Legal, and Supply Challenges in Pharmacy Practice

The rising use of prescription stimulants in the US presents significant safety risks, legal challenges, and supply chain shortages, emphasizing the need for pharmacist involvement in promoting responsible prescribing.

For Optimal Bioavailability, Administer Dronedarone With a Complete Meal

Bioavailability of dronedarone is markedly increased when administered with food. To maximize absorption, patients should take dronedarone with a complete meal (ideally >500 calories).

Risks and Impacts of Cannabis Use During Pregnancy: A Growing Concern for Neonatal Health

Cannabis use during pregnancy may harm fetal development and long-term health.

Cardiovascular Risks of BTK Inhibitors: What Pharmacists Need to Know

Sarah Spinler, PharmD, FCCP, FAHA, FASHP, AACC, discussed management of atrial fibrillation in patients with cancer.

Optimizing Health System Pharmacies: Leveraging Data, Performance Indicators, and Automation

Health system pharmacies can enhance operational and financial performance by leveraging key performance indicators, data-driven tools, and automation, ultimately supporting the broader health system’s adaptability and growth within an evolving health care landscape.

From Type 1 to Type 2 and Beyond: Navigating the Landscape of Diabetes

Explore the rising prevalence of diabetes in the US, its various types, and the critical role pharmacists play in patient care.

The Expanding Role of CDK 4/6 Inhibitors in Breast Cancer Treatment

Cyclin-dependent kinase 4/6 (CDK 4/6) inhibitors have transformed the treatment of hormone receptor-positive/HER2-negative breast cancer across metastatic and early-stage settings, with ongoing research exploring their potential in additional breast cancer subtypes, combination therapies, and aggressive disease scenarios.

Neuriva: A Closer Look at the Efficacy and Safety of this Popular Supplement

Managing Sickle Cell Disease: Modern Pain Strategies and Pharmacologic Advances

Effective SCD pain management requires an integrated, multimodal strategy across outpatient and inpatient settings.

The Evolving Landscape of Polycythemia Vera Treatment

Current treatment strategies are aimed at reducing hematocrit and symptom burden through phlebotomy, aspirin, and cytoreductive agents, while emerging therapies offer promise for better disease control and quality of life.

Why SSRI Tapering Gets Harder at Lower Doses: The Role of Serotonin Transporter Occupancy

Serotonin transporter occupancy explains sertraline withdrawal symptoms and helps distinguish relapse.

TrumpRx Explained: Implications for Community Pharmacy Practice

TrumpRx offers select branded drugs at cash prices outside insurance, requiring pharmacists to guide patients on cost comparisons, coverage limitations, and safe medication management, according to Ronna Hauser, PharmD.

A Pharmacist’s Guide to Blockbuster Patent Expirations: 2025 and Beyond

This shift brings new responsibilities and opportunities, from managing inventory changes to counseling patients on alternative therapies.

Hawaii Reaches Settlement With Plavix Makers Over Deceptive Labeling

Hawaii has secured a $700 million settlement with the manufacturers of Plavix following a lawsuit alleging they concealed for years the drug's ineffectiveness and potential danger for individuals of East Asian or Pacific Islander descent, a risk that the FDA later required to be disclosed with a boxed warning.

Selection Considerations for Abemaciclib Versus Ribociclib in Early HR+/HER2- Breast Cancer: Efficacy, Safety, and Long-Term Outcomes

New research highlights abemaciclib and ribociclib as promising treatments for early HR-positive, HER2-negative breast cancer, emphasizing survival benefits and adverse effects.

Pharmacists Can Advance Immunomodulatory Care in Multiple Myeloma

Pharmacists can play a pivotal role in overcoming the many challenges that exist in accessing immunomodulatory drugs in multiple myeloma.

Navigating Prescription Stimulant Use: Safety, Legal, and Supply Challenges in Pharmacy Practice

The rising use of prescription stimulants in the US presents significant safety risks, legal challenges, and supply chain shortages, emphasizing the need for pharmacist involvement in promoting responsible prescribing.

Why Modest Trial Gains Aren’t Enough: The Case for Value-Driven Drug Approval

Patients need evidence that reflects real benefit.

Neuriva: A Closer Look at the Efficacy and Safety of this Popular Supplement

Bridging the Gap: Field Teams and Hubs Supporting Patient Care

Enhanced communication between field representatives and case managers improves medication access for patients with rare diseases.

Evaluation of a Pharmacy-Delivered Oncofertility Intervention

This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025.

Hormone Replacement Therapy for Menopause: Revisiting Evidence and Looking Ahead

Reevaluating menopause hormone therapy myths, risks, timing, and access.

Interprofessional Education in Medical School Creates a Collaborative Environment

Adaptability, teamwork, and a culture of lifetime learning are required virtues in our rapidly evolving medical landscape.

The Future of Cancer Drug Development: Advancements, Challenges, and the Transformative Role of AI

AI is revolutionizing oncology drug development, enhancing therapeutic identification and reducing approval times, but use of this tool must be carefully implemented to mitigate risks and ensure regulatory compliance.